# Memantine and Validation of a New Alzheimer's Disease Scale

> **NCT00804271** · PHASE3 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 487 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** memantine

## Key facts

- **NCT ID:** NCT00804271
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 487 (ACTUAL)
- **Last updated:** 2013-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00804271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00804271, "Memantine and Validation of a New Alzheimer's Disease Scale". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00804271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*